文献速递胸部肿瘤放疗放疗物理与技术

心脏放疗剂量对非小细胞肺癌放疗后生存的影响

The Impact of Cardiac Radiation Dosimetry on Survival After Radiation Therapy for Non-Small Cell Lung Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2017-04-27

研究分析IDEAL-CRT试验中78例接受同步放化疗的非小细胞肺癌患者,探讨心脏放疗剂量、心电图改变与总生存的关系。结果显示6个月时38%患者出现心电图改变,且心电图改变、左心房壁及心脏特定剂量主成分得分与更高死亡风险相关。

要点

  • 6个月时38%患者出现心电图改变,与更高死亡风险相关。
  • 左心房壁及心脏接受63至69 Gy体积相关主成分得分越高,死亡风险越高。
  • 心电图改变、左心房壁主成分得分和PTV大小在多变量模型中保留。

核心结论

  • 心电图改变及心脏或左心房壁接受63至69 Gy体积相关得分与更高死亡风险相关。

研究设计与样本

  • 分析IDEAL-CRT试验中78例接受同步放化疗、肿瘤剂量63至73 Gy的非小细胞肺癌患者的剂量学与生存数据。
  • 对53例患者分析基线和放疗后6个月心电图,按有无任何心电图改变二分类。

主要发现

  • 38%患者6个月时出现心电图改变。
  • 单变量分析中,左心房壁PC6、心脏PC6、任何心电图改变和PTV较大与更高死亡风险显著相关(P=.003、.009、.029、.037)。
  • 心脏PC6和左心房壁PC6代表心脏和左心房壁接受63至69 Gy的较大体积。
  • 心脏接受≥63 Gy剂量集中在左心房壁,心脏PC6与左心房壁PC6高度相关。
  • 多变量模型保留任何心电图改变、左心房壁PC6得分和PTV大小。

关键数值与推荐

  • 心脏PC6和左心房壁PC6反映心脏或左心房壁接受63至69 Gy的体积。

临床怎么用

  • 放疗计划时应关注心脏及左心房壁接受63至69 Gy的体积。
  • 放疗后6个月心电图改变可能提示更高死亡风险。

局限性

  • 研究为小样本队列。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The heart receives high radiation doses during radiation therapy of advanced-stage lung cancer. We have explored associations between overall survival, cardiac radiation doses, and electrocardiographic (ECG) changes in patients treated in IDEAL-CRT, a trial of isotoxically escalated concurrent chemoradiation delivering tumor doses of 63 to 73 Gy. METHODS AND MATERIALS: Dosimetric and survival data were analyzed for 78 patients. The whole heart, pericardium, AV node, and walls of left and right atria (LA/RA-Wall) and ventricles (LV/RV-Wall) were outlined on radiation therapy planning scans, and differential dose-volume histograms (dDVHs) were calculated. For each structure, dDVHs were approximated using the average dDVH and the 10 highest-ranked structure-specific principal components (PCs). ECGs at baseline and 6 months after radiation therapy were analyzed for 53 patients, dichotomizing patients according to presence or absence of "any ECG change" (conduction or ischemic/pericarditis-like change). All-cause death rate (DR) was analyzed from the start of treatment using Cox regression. RESULTS: 38% of patients had ECG changes at 6 months. On univariable analysis, higher scores for LA-Wall-PC6, Heart-PC6, "any ECG change," and larger planning target volume (PTV) were significantly associated with higher DR (P=.003, .009, .029, and .037, respectively). Heart-PC6 and LA-Wall-PC6 represent larger volumes of whole heart and left atrial wall receiving 63 to 69 Gy. Cardiac doses ≥63 Gy were concentrated in the LA-Wall, and consequently Heart-PC6 was highly correlated with LA-Wall-PC6. "Any ECG change," LA-Wall-PC6 scores, and PTV size were retained in the multivariable model. CONCLUSIONS: We found associations between higher DR and conduction or ischemic/pericarditis-like changes on ECG at 6 months, and between higher DR and higher Heart-PC6 or LA-Wall-PC6 scores, which are closely related to heart or left atrial wall volumes receiving 63 to 69 Gy in this small cohort of patients.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Vivekanandan S, Landau DB, Counsell N, et al. The Impact of Cardiac Radiation Dosimetry on Survival After Radiation Therapy for Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2017. PMID: 28816160. doi:10.1016/j.ijrobp.2017.04.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。